The role of modelling in reimbursement decisions - An international perspective;Modellierungen als grundlage für die erstattung medizinischer leistungen - Eine internationale perspektive

Gesundheitsokonomie und Qualitatsmanagement

Volumn 10, Issue SUPPL. 2, 2005, Pages

  Rohrbacher, Rainer ^a  

^a HealthEcon Ltd   (Switzerland)

Author keywords

Decision making; Evaluation; Guidelines; Modelling; Reimbursement

Indexed keywords

AUSTRALIA; BUDGET; CANADA; DRUG APPROVAL; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE SYSTEM; LICENCE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PROCESS MODEL; REIMBURSEMENT; REVIEW;

EID: 24744440158     PISSN: 14322625     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858413     Document Type: Review

References (3)

1. Mitchell A. International experiences in pharmacoeconomics, Australia. Vortrag Brasilia 2003 (www.anvisa.gov.br/monitora/Seminarios/farmacoeconomia/ 2211_8h30_andrew.ppt).
2. Gregoire JP, MacNeil P, Skilton K, Moisan J, Menon D, Jacobs P, McKenzie E, Ferguson B. Inter-provincial Variation in Government Drug Formularies. Canadian Journal of Public Health 2001; 92: 309
3. Pausjenssen AM, Singer PA, Detsky AS. Ontario's Formulary Committee. How Recommendations Are Made. Pharmacoeconomics 2003; 21: 288